Białystok PLUS - Polish Longitudinal University Study

Enrolling by invitationOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2029

Conditions
Cardiovascular DiseasesDiabetesNeuro-Degenerative DiseaseObesityPulmonary DiseaseNeoplastic Disease
Interventions
OTHER

Discovering novel risk factors.

The study protocol includes multiple imaging and functional investigations (including heart, carotid, thyroid, liver ultrasound, fundoscopy, plethysmography, pulse wave velocity, ankle-brachial index, ECG, body composition measured by bioimpedance and dual energy x-ray absorptiometry, anthropometric assessment, rhinometry, hand grip test, oral glucose tolerance test, advance glycation end-products measurement, voice recording. There will be a detailed and verified questionnaires concerning various activities of the subject: physical activity, depression, sino-nasal symptoms, prostate hypertrophy, female urinary tract symptoms, quality of life, smoking and drinking addiction, hirsutism.

Trial Locations (1)

15-089

Medical University of Bialystok, Bialystok

All Listed Sponsors
collaborator

University Medicine Greifswald

OTHER

collaborator

City of Białystok

UNKNOWN

collaborator

Marshall's Office of Podlaskie Voivodship

UNKNOWN

lead

Medical University of Bialystok

OTHER